Neurorehabilitation and neural repair · 2023 · 17 citations · 31 references
MedicineNeurobiologyNeuroscienceInflammationMolecular NeuroscienceNeuroimmunologyGlial Response To InjuryMicroglia BiologyNeuroinflammationNeuroprotectionSpinal Cord InjuryTraumatic Brain InjuryMicroglial Responses To InjuryNeuroinflammation After InjuryNeuroprotection In Spinal TraumaNrf2 Signaling PathwaySirtuin RegulationSpinal Cord Injury ModelsSpinal Cord Injury NeuroprotectionTraumatic Spinal Cord Injury
BACKGROUND: Microglial-induced inflammation plays a crucial role in the pathophysiological process of nervous system injury, however, still lacks effective therapeutic agents. Previously, we discovered that the inhibition of histone deacetylase 3 (HDAC3) exerts anti-inflammatory effects after traumatic spinal cord injury (SCI), whereas little is known about its underlying mechanism. Therefore, the present study aimed to explore the effects and potential mechanisms of HDAC3 on neuroinflammation and microglial function. METHODS: Rats were randomized into 4 groups: sham group, SCI group, SCI + vehicle group, and SCI + RGF966 group. To examine the effect of HDAC3 on neurological deficit after SCI, we gathered data using the Basso Beattie Bresnahan locomotion scale, the inclined plane test, the blood-spinal cord barrier, junction protein expression, and Nissl staining. We also evaluated microglial activation and inflammatory factor levels. Immunofluorescence analysis, immunohistochemical analysis, western blotting, and quantitative real-time polymerase chain reaction were performed to examine the regulation of the Sirtuin 1 (SIRT1)/nuclear factor-erythroid 2-related factor 2 (Nrf2) pathway. RESULTS: The results showed that HDAC3 inhibition significantly ameliorated Basso-Beattie-Bresnahan (BBB) permeability, brain edema, and improved neurological functions and junction protein levels. Additionally, HDAC3 inhibition significantly inhibited microglial activation, thereby reducing the levels of SCI-induced pro-inflammatory factors. Moreover, HDAC3 inhibition dramatically enhanced the expression of SIRT1 and increased both Nrf2 nuclear accumulation and transcriptional activity, thereby increasing downstream heme oxygenase-1 and NAD(P)H quinone oxidoreductase 1 expression. CONCLUSIONS: The results of this study suggest that HDAC3 inhibition protects the spinal cord from injury following SCI by inhibiting SCI-induced microglial activation and the subsequent inflammatory response via SIRT1/Nrf2 signaling pathway, highlighting HDAC3 as a potential therapeutic target for the treatment of SCI.
31
SIRT1 is downregulated by autophagy in senescence and ageing
Caiyue Xu, Lu Wang, Parinaz Fozouni et al. · Nature Cell Biology · 2020 · 463 citations · Full text
Microbiota-derived metabolite promotes HDAC3 activity in the gut
Shu-en Wu, Seika Hashimoto‐Hill, Vivienne Woo et al. · Nature · 2020 · 247 citations · Full text